Alloferon (4-13)

General Information


DRACP ID  DRACP04005

Peptide Name   Alloferon (4-13)

Sequence  SGHGQHGVHG

Sequence Length  10

UniProt ID  P83412 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C39H57N17O13

Absent amino acids  ACDEFIKLMNPRTWY

Common amino acids  G

Mass  113271

Pl  7.81

Basic residues  3

Acidic residues  0

Hydrophobic residues  1

Net charge  3

Boman Index  -1512

Hydrophobicity  -113

Aliphatic Index  29

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22883213

Title  New alloferon analogues: synthesis and antiviral properties

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15531

DRACP is developed by Dr.Zheng's team.